ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

New memoir “Everlasting Rose” by Rose Murphy is released, an incredible, inspiring story of surviving disease, maintaining hope, and living with joy

New memoir "Everlasting Rose" by Rose Murphy is released, an incredible, inspiring story of surviving disease, maintaining hope, and living with joy

“Everlasting Rose” by Rose Murphy RN, BSN, MHA has been released worldwide. This empowering, 130-page memoir tells the harrowing, inspiring true story of the author’s journey through multiple bouts with cancer and a litany of other diseases and treatments. Diagnosed with pancreatic cancer at the age of 56, Murphy – now 80 years old – aims to help others navigate challenges, find perseverance, and maintain hope by sharing her experiences with humor and honesty.

Murphy’s career as a registered nurse gives her particular insight into the patient experience, and her wisdom offers perspective through the lens of both a survivor and a medical professional. From her initial pancreatic cancer diagnosis, her long journey from 56 to 80 was marked by t-cell lymphoma, leukemia, autoimmune disease, sepsis, a car accident, and other setbacks.

These multiple diseases and complications gave Murphy a slim chance of survival, but by enduring chemotherapy, radiation, a bone marrow transplant, and countless hours in pain, she is still living a vibrant life of joy, using her firsthand experience to help others do the same. Throughout the book, she provides tips for every aspect of managing illness, from tools for disease prevention to maintaining a positive attitude.

Her personal experiences and medical expertise, alongside a willingness to be candid about the best and worst parts of her journey, make this memoir an empowering, hopeful read for cancer patients, those suffering from other illnesses, and their loved ones alike.

Everlasting Rose (ISBN: 9781965340134 / 9781965340127) can be purchased through retailers worldwide, including Barnes and Noble and Amazon. The hardcover retails for $22.99, the paperback retails for $15.99, and the ebook retails for $5.99. Review copies and interviews are available upon request.

From the back cover:

Through a humorous lens, I took a dramatic journey of survival through three life threatening cancers (pancreatic, t-cell lymphoma, and leukemia), and their treatments (chemo, radiation, and bone marrow transplant), plus sepsis and other conditions from age 56 to my present age of 80. Everlasting Rose provides you with hope and disease prevention tools and techniques to overcome the odds. With all these conditions it was determined that I had a 1 in 1,000 chance of survival. My mission is to help you with your journey.

About the author:

In the beginning I was a Catholic Italian girl, growing up in a sheltered Italian community and in the end, I had traveled extensively in the United States and Europe. My education as a nurse with a Bachelor’s and Masters afforded me opportunities to experience many aspects of health care: teaching, administration, sales, and consulting. However, at age 56 I was diagnosed with pancreatic cancer and my long tortuous journey through disease after disease began. During these years I endured much pain, suffering and anxiety. However, I always stayed positive, even joyful and hopeful for the next day. I am now 80 and would like to share my unbelievable survival story with you.

About MindStir Media:

MindStir Media LLC is an award-winning book publisher. To learn more about publishing a book with MindStir Media, visit http://mindstirmedia.com or call 800-767-0531.

Media Contact
Company Name: MindStir Media LLC
Contact Person: Jen McNabney
Email: Send Email
Phone: 800-767-0531
Address:1 New Hampshire Ave Suite 125
City: Portsmouth
State: NH
Country: United States
Website: https://mindstirmedia.com/


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.